Epitomee Medical Ltd. Logo

Epitomee Medical Ltd.

Develops ingestible therapeutic devices for chronic diseases.

EPIT | TA

Overview

Corporate Details

ISIN(s):
IL0011825911
LEI:
Country:
Israel
Address:
17 Hatochen, 3079892 Caesarea

Description

Epitomee Medical Ltd. develops and commercializes ingestible therapeutic devices for chronic diseases. The company's core technology is a platform based on a self-administered, swallowable capsule that deploys targeted therapies along the gastrointestinal (GI) tract. These devices are engineered for controlled activation in specific regions, such as the stomach or small intestine, to provide mechano-sensory stimulation, targeted drug delivery, or absorption management. The therapies have a predetermined duration of activity, after which the device dissolves and is passed naturally. The company's flagship product is an FDA-cleared, drug-free weight management capsule. Epitomee is also advancing a platform for the oral delivery of biologic drugs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-30 10:58
Investor Presentation
Hebrew (modern) 1.1 MB
2023-11-30 10:58
Investor Presentation
Russian 42.4 KB
2023-09-12 10:37
Presentation- September 2023
English 2.4 MB
2023-09-12 10:37
Presentation- September 2023
Russian 42.1 KB
2022-03-29 13:15
TASE Indices – Epitomee Med Factor Correction
Hebrew (modern) 158.0 KB
2022-02-17 19:30
Will be added to the respective indices thru the fast track on March 3rd , 2022…
Hebrew (modern) 327.0 KB
2021-12-21 18:44
Will be add to the TA-Tech Elite Index On March 3rd, 2021 thru the Fast Track
Hebrew (modern) 161.3 KB
2021-12-14 16:03
Opening of Trading On December 15 2021-EPITOMEE MED
Hebrew (modern) 175.6 KB
2021-12-14 15:03
Opening of Trading On December 15 2021-EPITOMEE MED
Hebrew (modern) 175.6 KB
2021-12-13 12:45
Identifying Details of New Security- EPITOMEE MED
Hebrew (modern) 174.7 KB
2021-11-29 18:33
Investor Presentation-November 2021
English 2.8 MB
2021-11-29 18:33
Investor Presentation-November 2021
Russian 41.6 KB

Automate Your Workflow. Get a real-time feed of all Epitomee Medical Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epitomee Medical Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epitomee Medical Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Basilea Pharmaceutica AG Logo
Biopharmaceutical firm developing drugs for severe bacterial and fungal infections.
Switzerland
BSLN
BASKHANBIOPharma Inc. Logo
Offers pharmaceuticals, medical devices, and health products for pain management.
South Korea
354390
Bausch Health Companies Inc. Logo
Develops, manufactures, and markets pharmaceuticals, OTC products, and medical devices.
United States of America
BHC
Bausch & Lomb Corp Logo
Global eye health company offering vision care, pharmaceutical, and surgical products.
United States of America
BLCO
Bavarian Nordic Logo
Biotechnology company developing and commercializing vaccines for infectious diseases.
Denmark
BAVA
BAXTER INTERNATIONAL INC Logo
Provides essential products for renal care, hospital, and surgical settings.
United States of America
BAX
Bayer AG Logo
A global life science company with core competencies in healthcare and nutrition.
Germany
BAY
BBS-Bioactive Bone Substitutes Oyj Logo
Develops and manufactures bioactive medical implants for orthopedic surgery.
Finland
BONE
BCWORLDPHARM Co., Ltd. Logo
Pharmaceutical company specializing in the R&D and manufacturing of prescription drugs.
South Korea
200780
Beam Therapeutics Inc. Logo
Develops precision genetic medicines using proprietary base editing technology.
United States of America
BEAM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.